Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Apply
Zanubrutinib & Sonrotoclax
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step